Korea Investment CORP Has $2.40 Million Holdings in Hologic, Inc. (HOLX)

Korea Investment CORP lessened its holdings in Hologic, Inc. (NASDAQ:HOLX) by 62.5% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 60,378 shares of the medical equipment provider’s stock after selling 100,600 shares during the period. Korea Investment CORP’s holdings in Hologic were worth $2,400,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also made changes to their positions in HOLX. Amundi Pioneer Asset Management Inc. increased its holdings in Hologic by 818.9% in the 1st quarter. Amundi Pioneer Asset Management Inc. now owns 1,521,695 shares of the medical equipment provider’s stock valued at $56,851,000 after buying an additional 1,356,091 shares during the period. Natixis bought a new stake in Hologic in the 1st quarter valued at $42,165,000. Parnassus Investments CA increased its holdings in Hologic by 3.4% in the 2nd quarter. Parnassus Investments CA now owns 16,241,334 shares of the medical equipment provider’s stock valued at $645,593,000 after buying an additional 535,745 shares during the period. Mawer Investment Management Ltd. bought a new stake in Hologic in the 2nd quarter valued at $17,025,000. Finally, Standard Life Aberdeen plc increased its holdings in Hologic by 147.0% in the 2nd quarter. Standard Life Aberdeen plc now owns 716,348 shares of the medical equipment provider’s stock valued at $28,479,000 after buying an additional 426,286 shares during the period. 98.65% of the stock is currently owned by hedge funds and other institutional investors.

HOLX opened at $39.64 on Friday. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.99 and a current ratio of 1.29. Hologic, Inc. has a twelve month low of $35.10 and a twelve month high of $45.09. The stock has a market capitalization of $10.63 billion, a PE ratio of 18.08, a PEG ratio of 1.78 and a beta of 0.65.

Hologic (NASDAQ:HOLX) last posted its earnings results on Tuesday, July 31st. The medical equipment provider reported $0.58 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.56 by $0.02. Hologic had a negative net margin of 2.47% and a positive return on equity of 22.18%. The business had revenue of $824.00 million for the quarter, compared to analyst estimates of $800.14 million. analysts expect that Hologic, Inc. will post 2.24 earnings per share for the current year.

Several equities research analysts have issued reports on the stock. Needham & Company LLC boosted their price target on shares of Hologic from $43.00 to $48.00 and gave the company a “buy” rating in a report on Wednesday, August 1st. BidaskClub raised shares of Hologic from a “hold” rating to a “buy” rating in a report on Wednesday, August 1st. Deutsche Bank upped their target price on shares of Hologic from $42.00 to $45.00 and gave the stock a “hold” rating in a report on Wednesday, August 1st. Zacks Investment Research raised shares of Hologic from a “sell” rating to a “hold” rating in a report on Thursday, August 2nd. Finally, Bank of America upped their target price on shares of Hologic from $44.00 to $47.00 and gave the stock a “buy” rating in a report on Wednesday, August 1st. Ten research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $44.47.

Hologic Company Profile

Hologic, Inc develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women in the United States, Europe, the Asia-Pacific, and internationally. The company operates through five segments: Diagnostics, Breast Health, Medical Aesthetics, GYN Surgical, and Skeletal Health.

See Also: How to Profit and Limit Losses With Stop Orders

Want to see what other hedge funds are holding HOLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Hologic, Inc. (NASDAQ:HOLX).

Institutional Ownership by Quarter for Hologic (NASDAQ:HOLX)

Receive News & Ratings for Hologic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hologic and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply